Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Agilon Health (AGL) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to 8.88%.

  • Agilon Health's EBITDA Margin rose 1100.0% to 8.88% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.16%, marking a year-over-year decrease of 1400.0%. This contributed to the annual value of 4.62% for FY2024, which is 5700.0% up from last year.
  • According to the latest figures from Q3 2025, Agilon Health's EBITDA Margin is 8.88%, which was up 1100.0% from 8.04% recorded in Q2 2025.
  • In the past 5 years, Agilon Health's EBITDA Margin registered a high of 0.2% during Q1 2023, and its lowest value of 59.68% during Q2 2021.
  • Its 5-year average for EBITDA Margin is 8.76%, with a median of 4.05% in 2022.
  • Its EBITDA Margin has fluctuated over the past 5 years, first plummeted by -594200bps in 2021, then skyrocketed by 566300bps in 2022.
  • Quarter analysis of 5 years shows Agilon Health's EBITDA Margin stood at 17.02% in 2021, then increased by 16bps to 14.3% in 2022, then decreased by -7bps to 15.33% in 2023, then surged by 55bps to 6.88% in 2024, then dropped by -29bps to 8.88% in 2025.
  • Its last three reported values are 8.88% in Q3 2025, 8.04% for Q2 2025, and 1.19% during Q1 2025.